CRN supports FDA action against marketing pure powdered caffeine to consumers FDA approves updated labeling for Simponi Aria McKesson public policy forum encourages pharmacists to get involved FDA unveils draft guidance for naming biosimilars E-prescribing controlled substances now legal nationwide FDA approves Synjardy tablets NACDS honors two chains for political advocacy Educating policy-makers to effect Rx change Unleashing innovative, competitive new companies Value, results center stage in health care First Previous 56 57 58 59 60 Next Last